Summary. Dot-blot analysis of whole-cell suspensions of meningococci showed that 8 1 O h of B : 15 : P1.16 strains from patients reacted with a monoclonal antibody (MAb) against subtype PI .7. The remaining strains, which did not react on dot-blots or in ELISA, demonstrated the P1.7 subtype epitope on immunoblots after denaturation of the cells with sodium dodecyl sulphate. The monomeric class 1 proteins of the two P1.16 subtype variants had slightly different mol. wts, but bound the PI .7 antibody equally well. These results were explained by a deletion of three codons in the gene encoding the first variable region of the P 1.16 class 1 protein. The deletion accounted for the non-exposure of the P1.7 epitope on native cells. Other patient strains, with subtypes P1.3, P1.9 or without any known subtype, also showed a binding site for the P1.7 MAb, which became available only after denaturation. Demonstration of inaccessible epitopes may have consequences for subtype designations and vaccine development.
Introduction
The class 1 protein is one of the major outermembrane proteins of Neisseria meningitidis, and antigenic variations of this protein define the subtype of a meningococcal strain.' To date, monoclonal antibodies (MAbs) have been made against c. 15 different subtypes,'-8 and the binding of two different subtype MAbs to some class 1 proteins has been demonstrated. 4 7 '-lo Expression of the class 1 protein is controlled by the porA gene." The predicted amino-acid sequence of the gene shows homology with the gonococcal PI pore proteins,12' l3 and a pore function with a slight cationic selectivity has been demonstrated in ~i t r 0 . l~ Two major variable regions are present in the amino-acid sequences of different class 1 proteins in which the subtype-specific epitopes are 10calised.l~~ l5 Thus, the subtype P1.7,16 protein of the prototype strain 44/76 has the epitopes for the subtypes P1.7 and P1.16 MAbs in the first (VR1) and the second (VR2) variable region, re~pective1y.l~ Both regions are exposed on the cell surface, since the MAbs bind to whole cells and are bactericidal. 16 A dot-blot study of whole-cell suspensions of meningoc~cci~~ showed that many B : 15 : P1.16 strains from Norwegian patients also reacted with the P1.7 subtype MAb. This was similar to the prototype strain 44/76 .of serotype 15, which was originally isolated in Norway.1s The remaining B : 15 : PI. 16 strains did not react, but preliminary studies with a few such strains indicated binding of the P1.7 MAb after denaturation and imm~noblotting. ~~ In this study, we examined the reactions of more B : 15 : P1.16 strains and strains of other subtypes with the P1.7 MAb in dot-blotting, ELTSA and immunoblotting. The reason for the inaccessibility of the epitope in some strains was examined by DNA sequencing.
Materials and methods

Meningococcal strains
The serotypes and subtypes of 50 patient and 133 carrier strains, collected in Norway during 1987-1 988, have been described previo~sly.~ One hundred and one strains from Norwegian patients, collected during 1988-1990, 87 strains from various other parts of the world,lg and three patient strains from Chile were also studied .
Monoclonal antibodies
P1.Ham MAb was supplied by Dr F. E. Ashton. MAbs against serotype 15 (3-1-P15), subtypes P1.3 (12-1-P1.3) and P1.16 (3-1-P1.16) were supplied by Dr W. D. Zollinger. MAbs against subtypes P1.6 (MN19D6.13), P1.7 (MN14C11.6) and P1.9 (MN5-AlOF) were supplied by author J.T.P.
Dot-blotting and immunoblotting
These procedures were performed with whole-cell suspensions as described previo~sly.~ The cells were initially heat inactivated at 56°C for 30 min in phosphate-buffered saline."' Binding of the MAbs to the blotted antigens was detected with rabbit anti-mouse immunoglobulin conjugated to horseradish peroxidase (Dakopatts a/s, Denmark)." Cells used as antigens i n immunoblotting were either fully denatured by boiling with sample buffer" containing 2-mercaptoethanol and SDS 0-7 or denatured mildly by mixing with ice-cold sample buffer just before application on to SDS-PAGE gels containing acrylamide 12 O/O. The dilutions of the P1.7 MAb used in dot-blotting and iminunoblotting were 1 in 60000 and 1 in 20000, respectively. Mol. wt determinations were performed with a calibration kit from Pharmacia AB. Sweden.
Heat-inactivated cell suspensions served as antigens in ELISA. which was performed as described previously." The P1.7 MAb was diluted 1 in 10000.
Etiz?*riit~ clc~t.tr.r~~~hc~rcsis
Each of the 374 isolates was characterised by niultilocus enzyiiie analysis with starch gel electrophoresis and enzyme-specific staining." The assignment of the isolates to the ET-5 complex was based on the analyses of 14 different enzyme loci.23
Chromosomal DNA was isolated as described previously," except for an additional treatment of the DNA solution for 2 h with boiled RNAase A (Sigma 1 20 pg/ml before the second phenol-chloroform extraction. DNA concentration and purity were determined spectrophotometrically and electrophoretically. The primers, which were synthesised by the Biotechnologq Centre. Oslo, were P-1 182/ 1 159as which corresponded to the anti-sense strand of the region encoding the seven C-terminal amino acids of the class I protein and the TAA stop codon,13 and P-10/27s 5'-AAA CTT ACC GCC CTC GTA-3'. which coded for amino acids 4-9 of the signal peptide.
The polymerase chain reactions (PCRs) were performed as described by Maiden P t c11., 13 except that the concentration of the primers was 0 . 2 p~ to prevent nonspecific binding. The annealing temperature was 6O'C, 5'-TTA GAA TTT GTG GCG CAA ACC GAC-3'.
PC'R products were separated from the primers by centrifugation through Chroma Spin + TE 100 column> (Clontech Labs. CA. USA). The sequencing primer was P10/27s, which was labelled with (;j-"'P) ATP. and was used without purification as described by Embley." The composition of the sequencing reaction mixtures was as reported by Embley," but 4 111 of 10 x concentrated Taq-polymerase buffer was used; 4 pl of the reaction mixture was added to each of four tubes with 4 p l of termination mixture. strains also reacted with the P1.7 MAb on dot-blots and, therefore, had subtype P1.7,16, whereas 13 (1 9 %) of the strains had no reaction (table) . In ELISA, the latter strains showed no binding of the P1.7 MAb. These analyses were performed with bacteria that had been inactivated at 56°C for 30 min and stored as cell suspensions at 4°C.20 The binding patterns on dotblots of strains representing the two different subtypes P1.16 and P1.7,16 with the P1.16 and P1.7 MAbs are shown in fig. 1A . All strains expressed similar levels of class 1 proteins in SDS-PAGE gels.
When cell suspensions of strains with the two kinds of subtypes were boiled with SDS-containing sample buffer before gel electrophoresis, the monomeric class 1 proteins reacted equally well with the P1.7 MAb on immunoblots. However, their mol. wts were slightly different ( fig. 1B) To examine whether less harsh denaturation of the cells before immunoblotting would give the same response as the more native antigens on dot-blots, cells 11 Reacted with P1 .Ham. with the two subtype proteins were denatured mildly by mixing with cold sample buffer containing SDS before electrophoresis. Several high mol. wt bands reacting with the P1.7 MAb were observed with a trace of monomeric class 1 proteins ( fig. 1C) . Strains with the two kinds of subtype proteins showed a similar pattern and intensity of the polymeric immunoreactive bands. Thus, mild denaturation of the antigens with SDS was sufficient to expose or unmask the epitope for binding with the P1.7 MAb. The finding of an intact P1.7 epitope in such P1.16 strains and also the lower mol. wt of their class 1 protein suggested the possibility of a deletion in the protein. DNA was extracted from three B : 15 : P1.16 strains with masked P1.7 epitope. The extracted DNA was subjected to PCR and the products were sequenced as detailed above. The three strains had identical nucleotide sequences in VR1 of the protein in which the P1.7 epitope is located.'',16 The nucleotide sequence and the resulting amino-acid sequence of VR1 are shown in fig. 3 . When the strains with a masked P1.7 epitope were compared to the corresponding amino-acid sequence of the P1. 7 ( 3 3 O l O ) strains reacted with the P1.7 MAb after denaturation and thus carried a inaskcd P1.7 epitope. In contrast. none of the 15 :-isolates from carriers in our collection reacted with the P1.7 reagent on blots (table). They had a different subtype, previously defined as subtype P1.6;'*' they did not belong to the ET-5 complex, and only one strain bound the P1.Ham MAb. The serotype 15 protein of these carrier strains had a lower mol. wt in SDS gels than the corresponding class 3 protein from 15 :-patient strains, which indicated differences in the serotype 15 proteins.
Some meningococci with other subtypes also expressed a masked PI .7 epitope. Five patient strains of subtype P1.3 from Chile and one Swiss strain with subtype P1.9, which did not bind the P1.7 MAb on dot-blots or in ELISA, reacted after immunoblotting (table). The mobilities of the class 1 protein bands reacting with each pair of MAbs were similar, as shown in fig. 2 . The strain from Switzerland and two of the Chilean strains bound the Pl.Ham MAb, and all the Chilean strains belonged to the ET-5 complex. The other patient or carrier strains with subtypes P1.3 or P1.9 did not bind the P1.7 MAb on immunoblots (table) . nor did they belong to the ET-5 complex or react with the P1.Ham MAb.
None of the prototype strains.' including that for subtype P1.9 (M982), revealed a masked P1.7 epitope on immunoblots.
Discussion
This report describes an epitope for the P1.7 subtype-specific MAb on some meningococci which is unavailable for antibody binding with intact cells when they are examined by dot-blotting and ELISA methods. The epitope, which was expressed by meningococci of different subtypes, was exposed only after denaturation of the cells with SDS, but not after heat inactivation at 56'C.''' After denaturation, class 1 proteins with the masked P1.7 epitope reacted as strongly with the P1.7 MAb as strains recognising the MAb in the native state, which indicated that the epitope was intact.
For Norwegian B : 15 : P1.16 patient strains which carried a masked P1.7 epitope, a deletion of three amino acids in VR1 of the class 1 protein was the most likely explanation for these findings. VR1 is located in loop 1 of the monomeric protein.'". '6 This loop is the longest and contains the linear epitope for the P1.7 MAb at its tip.16 A deletion will shorten the loop and pull the epitope somewhat closer to the outer membrane so that it may be masked by the other loops or by other molecules, e.g.. LPS.2g-3' SDS altered this . . CiCC AAA AGC CiC'A I ' A A CiCC GCT AAC GGT GGA GCG AGC GGT CAG GTA AAA GTT ACT AAG . The demonstration of an inaccessible P1.7 epitope may have consequences for the subtype designation of strains with such epitopes. This implies that strains with masked epitopes will not bind subtype MAbs in routine ELISA and dot-blot typing analyses. We propose to use parentheses to indicate a masked epitope, e.g., P1. (7), 16. There are also implications for vaccine development. Antibodies against class 1 proteins seem to be important, as class 1 protein-specific MAbs protected infant rats against bacterial chall e~~g e .~~ Furthermore, sera from vaccinees and patients contained class 1 protein a n t i b~d i e s ,~~ and a correlation was observed between the bactericidal activity of post-vaccination sera and class 1 protein antibody Thus, it may be of interest to examine whether the PI .7 MAb protects against challenge with strains having a masked P1.7 epitope and also, to determine whether the level of protection afforded by a vaccine with the P1.7,16 subtype protein differs against P1.16 strains with exposed or masked P1.7 epitopes.
